Upcoming Events
Log In
Pricing
Free Trial

Wk 3, Case 2 - Practice

HIDE

Male with history of thyroid cancer. Status post two stage thyroidectomy (2014 and 2020), I-131 ablation. The patient was found to have manubrial, lung and left cervical nodes metastasis, status post resection of manubrium, left neck dissection; wedge resection of right middle lobe metastasis in 2021. Patient is currently on sorafenib. PET/CT performed for restaging.

FDG was the tracer used.

Which of the following is present on the 18F-FDG PET/CT on this patient with thyroid cancer recurrence?

PrevNext

Report

Faculty

Riham El Khouli, MD

Associate Professor of Radiology, Chief, Division of Nuclear Medicine/Molecular Imaging & Radiotheranostics

University of Kentucky

Michael F. Shriver, MD

Director of Nuclear Medicine

Proscan-NCH Imaging

Tags

PET

Nuclear Medicine

CT

© 2025 Medality. All Rights Reserved.

Contact UsTerms of UsePrivacy Policy